RevascularizationNCT05168553
Evaluation of Revascularization of Failed Endodontically Treated Mature Permanent Teeth
A study testing Revascualrization and Conventional endodontic treatment in people with Revascularization, run by Minia University.
Trial summary
Retraetment of failed previous endodontic treated mature permenant teeth with revascularization versus retreatment by conventional endodontic treatment Read more about this study
- Who is it for?
- Ages 10 to 18 years
- Conditions the study is for
- Revascularization
- What is being tested?
- Revascualrization and Conventional endodontic treatment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 12 Dec 2021to 11 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Pescence of failed endodontic treated mature permenant tooth
- Healthy patients
- Age of 10 years to 18 years
Who cannot join
- Medically compromised patients
- Mentally compromised patients
About this study
Retraetment of failed previous endodontic treated mature permenant teeth with revascularization versus retreatment by conventional endodontic treatment
- Conditions
- Revascularization
- Being tested
- Revascualrization, Conventional endodontic treatment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RevascualrizationOther
Regain pulp vascularity for mature permenant teeth
Conventional endodontic treatmentOther
Root canal treatment of permenant mature teeth with mechanical preparation and cleaning followed by canal obturation by inert material ( gutta percha)
| Study group | Role | What they receive |
|---|---|---|
| Revasularization | Experimental | Not described Receives: Other: Revascualrization |
| Conventional endodontic treatment | Active comparator | Not described Receives: Other: Conventional endodontic treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical success
Number of participants with pain, mobility and/or fistulous tract (+/-)
Measured: 1 year
Radiographic success
Absence of periapical radiolucency
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Dec 2021
- Study start12 Dec 2021 (estimated)
- Primary completion11 Dec 2022 (estimated)
- Study completion11 Dec 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for RevascularizationStudies of the same condition, open and under way.
- More trials run by Minia UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Minia University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmad Elheeny, Minia University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05168553
- Sponsor's protocol ID
- 809
- Status last verified
- Dec 2021
- First submitted
- 12 Dec 2021
- Last updated
- 23 Dec 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Revascularization of Failed Endodontically Treated Mature Permanent Teeth
- ClinicalTrials.gov ID
- NCT05168553
- Acronym / sponsor ID
- 809
- Conditions
- Revascularization
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Minia UniversityUniversity, hospital or other
- Study start
- 12 Dec 2021 (estimated)
- Primary completion
- 11 Dec 2022 (estimated)
- Study completion
- 11 Dec 2022 (estimated)
- First posted
- 23 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Retraetment of failed previous endodontic treated mature permenant teeth with revascularization versus retreatment by conventional endodontic treatment
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Revasularization | Experimental | Other: Revascualrization |
| Conventional endodontic treatment | Active comparator | Other: Conventional endodontic treatment |
Who may qualify
- Ages
- 10 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Pescence of failed endodontic treated mature permenant tooth
- Healthy patients
- Age of 10 years to 18 years
Key exclusion criteria (2 listed)
- Medically compromised patients
- Mentally compromised patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RevascualrizationRegain pulp vascularity for mature permenant teeth | Other | Revasularization |
| Conventional endodontic treatmentRoot canal treatment of permenant mature teeth with mechanical preparation and cleaning followed by canal obturation by inert material ( gutta percha) | Other | Conventional endodontic treatment |
Primary outcome
Clinical success
Time frame: 1 year
Number of participants with pain, mobility and/or fistulous tract (+/-)
Radiographic success
Time frame: 1 year
Absence of periapical radiolucency
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Dec 2021.
Related trials for Revascularization
RecruitingPhase 3
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Peripheral Artery Disease (PAD)
Not yet recruiting
Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
Postoperative Atrial Fibrillation, Coronary Artery Disease
Active, not recruiting
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Thrombosis, Arterial Occlusive Diseases
Not yet recruitingObservational study
Incremental Prognostic Utility of CBC-derived Inflammatory Indices After Incomplete Coronary Revascularization: Association With 12-months Cardiovascular Outcomes
STEMI, High Risk NSTEMI
Recruiting
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
Atherosclerotic Renal Artery Stenosis, Fractional Flow Reserve
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Revascualrization and Conventional endodontic treatment in people with Revascularization, run by Minia University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical success (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2021.